NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $431,886 | +10.7% | 4,240 | 0.0% | 0.31% | +9.9% |
| Q2 2023 | $390,080 | 0.0% | 4,240 | 0.0% | 0.28% | 0.0% |
| Q1 2023 | $390,080 | +4.0% | 4,240 | +2.5% | 0.28% | 0.0% |
| Q4 2022 | $375,218 | +19.5% | 4,136 | 0.0% | 0.28% | +14.1% |
| Q3 2022 | $314,000 | -10.3% | 4,136 | 0.0% | 0.25% | -3.1% |
| Q2 2022 | $350,000 | -3.6% | 4,136 | 0.0% | 0.26% | +13.3% |
| Q1 2022 | $363,000 | +0.3% | 4,136 | 0.0% | 0.23% | +3.7% |
| Q4 2021 | $362,000 | +7.1% | 4,136 | 0.0% | 0.22% | -2.2% |
| Q3 2021 | $338,000 | +0.6% | 4,136 | +12.2% | 0.22% | -3.5% |
| Q2 2021 | $336,000 | +6.7% | 3,686 | 0.0% | 0.23% | -1.7% |
| Q1 2021 | $315,000 | -9.5% | 3,686 | 0.0% | 0.24% | -19.0% |
| Q4 2020 | $348,000 | +8.4% | 3,686 | 0.0% | 0.29% | -4.9% |
| Q3 2020 | $321,000 | -0.6% | 3,686 | -0.2% | 0.30% | -10.3% |
| Q2 2020 | $323,000 | +5.9% | 3,694 | 0.0% | 0.34% | -8.1% |
| Q1 2020 | $305,000 | -15.7% | 3,694 | -3.5% | 0.37% | +7.2% |
| Q4 2019 | $362,000 | – | 3,826 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXENCIAL WEALTH ADVISORS, LLC | 188,514 | $13,713,000 | 5.95% |
| PRENTISS SMITH & CO INC | 136,441 | $10,133,000 | 5.74% |
| MANAGED ASSET PORTFOLIOS, LLC | 204,985 | $15,225,000 | 5.46% |
| Osher Van de Voorde Investment Management | 108,725 | $8,075,000 | 4.40% |
| BROWN BROTHERS HARRIMAN & CO | 10,796,684 | $801,870,000 | 4.35% |
| SECTORAL ASSET MANAGEMENT INC | 472,296 | $35,077,000 | 4.10% |
| PROFESSIONAL ADVISORY SERVICES INC | 235,347 | $17,479,000 | 3.87% |
| Elefante Mark B | 5,619 | $417,000 | 3.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 255,000 | $18,959,000 | 3.71% |
| CGOV Asset Management | 997,161 | $98,662,000 | 3.61% |